Welcome To The Mannkind HUB On AGORACOM
Edit this title from the Fast Facts Section
Message: Conference Call to be held at 4:00 pm (EDT) today
Your Vote:
Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Picked this off yahoo from user hvacra250 but have not been able to confirm:
Conference Call to be held at 4:00 pm (EDT) today
VALENCIA, Calif.--(BUSINESS WIRE)--Aug. 14, 2013-- MannKind Corporation (Nasdaq:MNKD) today announced that it will hold a conference call at 4:00 pm (EDT) today to discuss preliminary results from Study 171 and Study 175, two Phase 3 clinical studies of AFREZZA® (insulin human [rDNA origin]) Inhalation Powder, an investigational, ultra rapid-acting mealtime insulin therapy administered using MannKind’s next-generation (Gen2) inhaler (also known as the Dreamboat™ inhaler).
conference call today at 4pmET 1-800-447-0521 or 1-847-413-3238. code 34077263
OOG
Loading...
Loading...
New Message
Please
login
to post a reply